LGM Pharma

LGM Pharma is a private, revenue-generating services company providing critical API sourcing and CDMO solutions to the pharmaceutical industry. Founded in 2004, it has evolved from an API distributor into a full-service partner offering strategic sourcing, formulation development, analytical testing, and regulatory support. The company mitigates supply chain risk through a vast network of pre-qualified manufacturers and is investing significantly in U.S. manufacturing capacity, with recent expansions in Texas and Colorado totaling $15M. Its business model is centered on enabling clients to bring generic and specialty drug products to market faster and more reliably.

Integrated global API sourcing network combined with full-service CDMO capabilities, including formulation development, analytical testing, regulatory support, and manufacturer management.

LGM competes in the fragmented CDMO and API sourcing market against large global players (e.g., Lonza, Catalent) and many niche specialists. Its differentiation lies in combining a robust API sourcing network with mid-scale, U.S.-based CDMO services and targeted regulatory expertise for generics and 505(b)(2) products.